Joseph D Turner Selected Research

Loiasis

1/2021	Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
2/2020	Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection.
12/2019	Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
1/2019	Mouse models of Loa loa.
1/2019	Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.
1/2018	Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.
4/2010	Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph D Turner Research Topics

Disease

26	Infections 12/2022 - 12/2003
13	Onchocerciasis 06/2022 - 04/2010
11	Filarial Elephantiasis (Lymphatic Filariasis) 12/2022 - 06/2005
8	Filariasis 01/2021 - 06/2005
7	Loiasis 01/2021 - 04/2010
3	Eosinophilia 01/2020 - 01/2018
3	Nematode Infections 01/2020 - 06/2005
2	Infertility (Sterility) 03/2020 - 01/2017
2	Reinfection 02/2020 - 11/2004
2	Ocular Onchocerciasis (River Blindness) 01/2019 - 01/2019
2	Neglected Diseases 01/2019 - 01/2018
2	Intestinal Volvulus (Volvulus) 10/2016 - 04/2010
1	Trichuriasis 01/2021
1	Lymphedema (Milroy Disease) 01/2021
1	Coinfection 01/2019
1	Cutaneous Leishmaniasis 02/2016
1	Parasitic Diseases (Parasitic Disease) 02/2016
1	Granuloma 08/2011
1	Fibrosis (Cirrhosis) 08/2011
1	Chronic Disease (Chronic Diseases) 08/2011
1	Keratitis 08/2009
1	Inflammation (Inflammations) 08/2009
1	HIV Infections (HIV Infection) 06/2005
1	Helminthiasis (Helminthiases) 12/2003

Drug/Important Bio-Agent (IBA)

11	Doxycycline (Periostat)FDA LinkGeneric 01/2021 - 06/2005
8	Pharmaceutical PreparationsIBA 01/2020 - 10/2016
7	Ivermectin (Mectizan)FDA Link 06/2022 - 04/2006
7	CytokinesIBA 02/2020 - 12/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 06/2005
4	AntigensIBA 02/2020 - 11/2004
3	Minocycline (Cyclops)FDA LinkGeneric 01/2019 - 03/2016
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2021 - 01/2020
2	Interleukin-13IBA 01/2020 - 11/2004
2	QuinazolinesIBA 01/2020 - 01/2019
2	InterleukinsIBA 01/2019 - 11/2004
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2018 - 01/2017
2	Albendazole (Albenza)FDA Link 11/2017 - 04/2006
2	Lipoproteins (Lipoprotein)IBA 10/2016 - 08/2009
2	LigandsIBA 11/2011 - 01/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011 - 08/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 11/2004
2	Interferon-gamma (Interferon, gamma)IBA 04/2008 - 11/2004
1	ChitinasesIBA 12/2022
1	TetracyclinesIBA 01/2021
1	benzimidazoleIBA 01/2021
1	Small Molecule LibrariesIBA 03/2020
1	AnthelminticsIBA 03/2020
1	ChemokinesIBA 02/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2020
1	OrganophosphatesIBA 12/2019
1	TemefosIBA 12/2019
1	flubendazoleIBA 01/2019
1	PleuromutilinsIBA 01/2019
1	BoronIBA 01/2019
1	SolutionsIBA 01/2019
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	MacrolidesIBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	autoclaved Leishmania major vaccineIBA 02/2016
1	VaccinesIBA 02/2016
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	PAM2-CSK4IBA 02/2016
1	Leishmaniasis VaccinesIBA 02/2016
1	LipopeptidesIBA 02/2016
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 11/2011
1	CollagenIBA 08/2011
1	Helminth AntigensIBA 04/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2008
1	Interleukin-10 (Interleukin 10)IBA 04/2008
1	MitogensIBA 04/2008
1	Bacterial AntigensIBA 04/2008
1	AllergensIBA 06/2005
1	Immunoglobulin E (IgE)IBA 06/2005
1	Immunoglobulin G (IgG)IBA 06/2005
1	Interleukin-5 (Interleukin 5)IBA 11/2004

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2017
2	Mass Drug Administration 01/2021 - 01/2019
2	Ligation 10/2016 - 01/2011
1	Drug Therapy (Chemotherapy) 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Injections 01/2019